RVTY Revvity, Inc. Common Stock
NYSE · Life Sciences Tools & Services · SEC EDGAR पर देखें ↗ बंद अक्ट 2, 2026 10-K/10-Q अग 11, 2026RVTY स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
RVTY स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।
| एक्स-डेट | स्प्लिट | प्रकार |
|---|---|---|
| 4 जून 2001 | 2-for-1 | फॉरवर्ड |
| 11 मई 1992 | 2-for-1 | फॉरवर्ड |
| 2 फ़रवरी 1982 | 2-for-1 | फॉरवर्ड |
| 4 फ़रवरी 1980 | 2-for-1 | फॉरवर्ड |
Revvity, Inc. Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
PerkinElmer, Inc., previously styled Perkin-Elmer, is an American global corporation that was founded in 1937 and originally focused on precision optics. Over the years it went into and out of several different businesses via acquisitions and divestitures; these included defense products, semiconductors, computer systems, and others. By the 21st century, PerkinElmer was focused in the business areas of diagnostics, life science research, food, environmental and industrial testing. Its capabilities include detection, imaging, informatics, and service. It produced analytical instruments, genetic testing and diagnostic tools, medical imaging components, software, instruments, and consumables for multiple end markets. PerkinElmer was part of the S&P 500 Index and operated in 190 countries.
Over its history, PerkinElmer has been split in two twice. In 1999, PerkinElmer merged with EG&G, with the ongoing Analytical Instruments Division of Perkin-Elmer keeping that name, while the life sciences division of the company became the separate PE Corporation. In 2022, a split of PerkinElmer resulted in one part, comprising applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but kept the PerkinElmer name. The other part, comprising life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc.
History
Founding
Richard Perkin was attending the Pratt Institute in Brooklyn to study chemical engineering, but left after a year to try his hand on Wall Street. Still interested in the sciences, he gave public lectures on various topics. Charles Elmer ran a firm that supplied court reporters and was nearing retirement when he attended one of Perkin's lectures on astronomy being held at the Brooklyn Institute of Arts and Sciences.
The two struck up a friendship over their shared interest in astronomy, and eventually came up with the idea of starting a firm to produce precision optics. Perkin raised US$15,000 from his relatives, while Elmer added US$5,000, and the firm was initially set up as a partnership on 19 April 1937. Initially, they worked from a small office in Manhattan, but soon opened a production facility in Jersey City. They incorporated the growing firm on 13 December 1939. A further move to Glenbrook in Connecticut in 1941 was quickly followed by another move to Norwalk, Connecticut, where the company remained until 2000. The opening of World War II led to significant expansion as the company produced optics for range finders, bombsights, and reconnaissance systems. This work led to the U.S. Navy awarding them the first "E" for Excellence award in 1942.
Perkin-Elmer retained a strong presence in the military field through the 1960s and at the same time was significantly involved with OAO-3 a 36-inch Ultra Violet Space Telescope and Skylab. They contributed to the Apollo program by development of a CO2 sensor that was, however, supplanted by a Coleman Instruments product. PE at the Norwalk plant also conducted one of the first researches into computer-digital enhancement of scanned images, contracted for application to the Corona spy satellite, film imagery. They were a primary supplier of the optical systems used in many reconnaissance platforms, first in aircraft and high-altitude balloons, and then in reconnaissance satellites. A significant advance was 1955's Transverse Panoramic Camera, which took images on 12 by 14 ft (3.7 by 4.3 m) wide frames that provided single-frame images from horizon to horizon from an aircraft flying at 40,000 ft altitude. Such systems remained a major part of the company's income, capped by the installation of laser retroreflectors on the Moon as part of the Apollo 11 mission.
Elmer died at age 83 in 1954, and the company began trading shares over the counter. The company was listed on the New York Stock Exchange on 13 December 1960. Perkin remained as president and CEO until June 1961, when Robert Lewis, previously of Argus Camera and Sylvania Electric Products, took over these roles. Perkin remained the chairman of the board until his death in 1969.
Semiconductor manufacturing
In 1967, the U.S. Air Force asked Perkin-Elmer to produce an all-optical "masking" system for semiconductor fabrication. Previous systems used a pattern, the "mask", which was pressed onto the surface of the silicon wafer as part of the photolithography process. Small bits of dirt or photoresist would stick the mask and ruin the patterning for subsequent chips, and it was not uncommon for the vast majority of the chips from a given wafer to malfunction. The Air Force, which by the late 1960s was highly reliant on integrated circuits, desired a more reliable system.
Perkin-Elmer responded with the Microprojector, which was essentially a large photocopier system. The mask was placed in a holder and never touched the surface of the chip. Instead, the image was projected onto the surface. Making this work required a complex 16-element lens system that focussed a narrow range of wavelengths of light onto the mask. The remainder of the light from the 1,000 watt mercury-vapor lamp was filtered out. PE also developed a micro-densitometer in 1967 that scanned micro-chips for quality control
Harold Hemstreet was convinced that the concept could be simplified, and Abe Offner began the development of a system using mirrors instead of lenses, which did not suffer from the multispectral focussing problems of lenses. The result of this research was the Projection Scanning Aligner, or Micralign, which made chip making an assembly-line task and improved the number of working chips from perhaps 10% to 70% overnight. Chip prices plummeted as a result, with examples like the MOS 6502 selling for about US$20 while the previous generation of designs like the Motorola 6800 sold for around US$250.
The Micralign was so successful that Perkin-Elmer became the largest single vendor in the chip space in three years. In spite of this success, the company was largely a has-been by the 1980s due to their late response to the introduction of the stepping aligner, which allowed a single small mask to be stepped across the wafer, rather than requiring a single large mask covering the entire wafer. The company never regained their lead, and sold the division to The Silicon Valley Group.
Lab equipment
Perkin Elmer was a leading developer and supplier of lab analytic equipment from the 1950's. By the 1960's the Norwalk/Wilton, CT facilities were developing and producing a wide variety of instruments including multi-spectral spectrometers (IR, visible, UV), gas chromatographs, and atomic absorption spectrometers and Raman spectrometers. The plants housed integrated research, engineering, production (optical and electronic) and support facilities. In the early 1990s, partnered with Cetus Corporation (and later Hoffmann-La Roche) to pioneer the polymerase chain reaction (PCR) equipment industry. Analytical-instruments business was also operated from 1954 to 2001 in Germany, by the Bodenseewerk Perkin-Elmer GmbH located in Überlingen at Lake Constance, and England (Perkin Elmer Ltd) at Beaconsfield in Buckinghamshire.
Computer Systems Division
Perkin-Elmer was involved in computer manufacture for a time. The Perkin-Elmer Computer Systems Division was formed through the purchase of Interdata, Inc., an independent computer manufacturer, in 1973–1974 for some US$63 million. This merger made Perkin-Elmer's annual sales rise to over US$200 million. This was also known as Perkin-Elmer's Data Systems Group. The 32-bit computers were very similar to an IBM System/370, but ran the OS/32MT operating system. In 1976, Perkin-Elmer acquired Wangco, a Los Angeles manufacturer of tape drives for $30 million in a stock swap.
The Computer Systems Division had a large presence in Monmouth County, New Jersey, with some 1,700 staff making it one of the county's largest private employers. Its plant in Oceanport had 800 employees alone. By the early-mid-1980s the computing group had sales of $259 million; while profitable, it tended to have reduced visibility within the computing industry due to being owned by a diversified parent.
The Wollongong Group provided the commercial version of the Unix port to the Interdata 7/32 hardware, known as Edition 7 Unix. The port was originally done by the University of Wollongong in New South Wales, Australia, and was the first UNIX port to hardware other than the Digital Equipment Corporation PDP family. By 1982, the Wollongong Group Edition 7 Unix and Programmer's Workbench (PWB) were available on models such as the Perkin-Elmer 3210 and 3240 minicomputers.
In 1985, the computing division of Perkin-Elmer was spun off as Concurrent Computer Corporation, with the goal of giving it and the parallel processing product a clearer identification within the computer industry. At first, the new company was a wholly owned subsidiary of Perkin-Elmer, but with the intentions of putting a minority ownership in the company up for a public stock sale. This was done one in February 1986, with Perkin-Elmer retaining an 82 percent stake in Concurrent. In 1988, there was a merger between Concurrent Computer Corporation and MASSCOMP; as part of the deal, Perkin-Elmer's share in Concurrent was bought out. At that point, Perkin-Elmer said they had culminated their multi-year process of exiting from computer market, allowing them to focus on their primary business segments.
1999
Modern PerkinElmer traces its history back to a merger between divisions of what had been two S&P 500 companies, EG&G Inc. (formerly NYSE: EGG) of Wellesley, Massachusetts and Perkin-Elmer (formerly NYSE: PKN) of Norwalk, Connecticut. On May 28, 1999, the non-government side of EG&G Inc. purchased the Analytical Instruments Division of Perkin-Elmer, its traditional business segment, for US$425 million, also assuming the Perkin-Elmer name and forming the new PerkinElmer company, with new officers and a new board of directors. At the time, EG&G made products for diverse industries including automotive, medical, aerospace and photography.
The old Perkin-Elmer Board of Directors and Officers remained at that reorganized company under its new name, PE Corporation. It had been the Life Sciences division of Perkin-Elmer, and its two component tracking stock business groups, Celera Genomics (NYSE: CRA) and PE Biosystems (formerly NYSE: PEB), were centrally involved in the highest profile biotechnology events of the decade, the intense race against the Human Genome Project consortium, which then resulted in the genomics segment of the technology bubble. Perkin-Elmer purchased the Boston operations of NEN Life Sciences in 2001.
Recently
In 1992, the company merged with Applied Biosystems. In 1997 they merged with PerSeptive Biosystems. On July 14, 1999, the new analytical instruments maker PerkinElmer cut 350 jobs, or 12%, in its cost reduction reorganization. In 2006, PerkinElmer sold off the Fluid Sciences division for approximately US$400 million; the aim of the selloff was to increase the strategic focus on its higher-growth health sciences and photonic markets. Following on from the selloff, a number of small businesses were acquired, including Spectral Genomics, Improvision, Evotec-Technologies, Euroscreen, ViaCell, and Avalon Instruments. The brand "Evotec-Technologies" remains the property of Evotec, the former owner company. PerkinElmer had a license to use the brand until the end of year 2007.
PerkinElmer has continued to expand its interest in medicine with the acquisitions of clinical laboratories, In July 2006, it acquired NTD Labs located on Long Island, New York. The laboratory specializes in prenatal screening during the first trimester of pregnancy. In 2007, it purchased ViaCell, Inc. for US$300 million, which included its offices in Boston and cord blood storage facility in Kentucky near Cincinnati. The company was renamed ViaCord.
In 2001 Perkin Elmer acquired Packard Bioscience Inc from its majority shareholder, Dick McKernen. This acquisition also came with Agincourt Technologies Inc and consolidated Perkin Elmer's position in laboratory robotics, in particular, liquid handling robots which were to prove essential for the high-throughput sequencing needed for the Human Genome Project.
In March 2008, PerkinElmer purchased Pediatrix Screening (formerly Neo Gen Screening), a laboratory located in Bridgeville, Pennsylvania specializing in screening newborns for various inborn errors of metabolism such as phenylketonuria, hypothyroidism, and sickle-cell disease. It renamed the laboratory PerkinElmer Genetics, Inc.
In May 2011, PerkinElmer announced the signature of an agreement to acquire CambridgeSoft, and the successful acquisition of ArtusLabs.
In September 2011, PerkinElmer bought Caliper Life Sciences for US$600 million.
In December 2014 PerkinElmer acquired Perten Instruments for US$266 million to expand in food testing.
In January 2016, PerkinElmer acquired Swedish firm Vanadis Diagnostics.
In February 2016 PerkinElmer acquired Delta Instruments.
In January 2017, the company announced it would acquire the Indian in vitro diagnostic company, Tulip Diagnostics. In May 2017, the company acquired Euroimmun Medical Laboratory Diagnostics for approximately US$1.3 billion.
In 2018, the company acquired Australian biotech company, RHS Ltd., Chinese manufacturer of analytical instruments, Shanghai Spectrum Instruments Co. Ltd., and France-based company Cisbio Bioassays, which specializes in diagnostics and drug discovery solutions.
In November 2020, PerkinElmer announced it would acquire Horizon Discovery Group for around US$383 million.
In March 2021, PerkinElmer announced that the company has completed its acquisition of Oxford Immunotec Global PLC (Oxford Immunotec). In May of the same year, the business announced it would purchase Nexcelom Bioscience for $260 million and Immunodiagnostic Systems Holdings PLC for $155 million. In June the company announced it would acquire SIRION Biotech, a specialist in viral vector gene delivery methods. In July the business announced it would acquire BioLegend for $5.25 billion.
Acquisition history
Programs
Hubble optics project
Perkin-Elmer's Danbury Optical System unit was commissioned to build the optical components of the Hubble Space Telescope. The construction of the main mirror began in 1979 and completed in 1981. The polishing process ran over budget and behind schedule, producing significant friction with NASA. Due to a miscalibrated null corrector, the primary mirror was also found to have a significant spherical aberration after reaching orbit on STS-31. Perkin-Elmer's own calculations and measurements revealed the primary mirror's surface discrepancies, but the company chose to withhold that data from NASA. A NASA investigation heavily criticized Perkin-Elmer for management failings, disregarding written quality guidelines, and ignoring test data that revealed the miscalibration. Corrective optics were installed on the telescope during the first Hubble service and repair mission STS-61. The correction, Corrective Optics Space Telescope Axial Replacement, was applied entirely to the secondary mirror and replaced existing instrumentation; the aberration of the primary mirror remained uncorrected.
The company agreed to pay US$15 million, essentially forgoing its fees in polishing the mirror, to avoid a threatened liability lawsuit under the False Claims Act by the Federal government. Hughes Aircraft, which acquired the Danbury Optical System unit one month after the launch of the telescope, paid US$10 million. The Justice Department asserted that the companies should have known about the flawed testing. Trade group Aerospace Industries Association protested when concerns were raised in the aerospace industry that aerospace companies might be held liable for failed equipment.
KH-9 Hexagon
Perkin-Elmer built the optical systems for the KH-9 Hexagon series of spy satellites at a facility in Danbury, Connecticut.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
| मेट्रिक | 5Y रुझान | RVTY | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| P/E | 46.75Y औसत ≈34.7 | ≈34.7 | 46.0 | अति मूल्यांकित | |
| P/S | 3.85Y औसत ≈5.1 | ≈5.1 | 7.1 | अल्पमूल्यित | |
| P/B (MRQ) | 2.35Y औसत ≈2.2 | ≈2.2 | 6.8 | अल्पमूल्यित | |
| EV / EBITDA | 17.35Y औसत ≈19.0 | ≈19.0 | 25.4 | अल्पमूल्यित | |
| Price / FCF (मूल्य / FCF) | 21.35Y औसत ≈291.5 | ≈291.5 | · | · | |
| Price / Cash Flow (मूल्य / नकदी प्रवाह) | 18.65Y औसत ≈46.4 | ≈46.4 | 28.0 | अल्पमूल्यित | |
| EV / Revenue (EV / राजस्व) | 4.65Y औसत ≈6.1 | ≈6.1 | · | · | |
| EV / FCF | 25.85Y औसत ≈341.5 | ≈341.5 | · | · | |
| मूल्य / मूर्त पुस्तक (MRQ) | 3.4 | · | · | · |
सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
| मेट्रिक | 5Y रुझान | RVTY | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Operating Margin (परिचालन मार्जिन) | 12.5%5Y औसत ≈16.9% | ≈16.9% | 17.4% | कमजोर | |
| EBITDA Margin (EBITDA मार्जिन) | 26.7%5Y औसत ≈30.0% | ≈30.0% | 18.6% | कमजोर | |
| Pretax Margin (प्रीटैक्स मार्जिन) | 9.4%5Y औसत ≈14.5% | ≈14.5% | 17.9% | कमजोर | |
| Net Profit Margin (शुद्ध लाभ मार्जिन) | 8.5%5Y औसत ≈15.9% | ≈15.9% | 14.7% | कमजोर | |
| ROA | 2.0%5Y औसत ≈4.2% | ≈4.2% | 9.8% | कमजोर | |
| ROE | 3.3%5Y औसत ≈7.4% | ≈7.4% | 11.0% | कमजोर | |
| ROIC | 3.0%5Y औसत ≈4.3% | ≈4.3% | 13.4% | कमजोर |
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
| मेट्रिक | 5Y रुझान | RVTY | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| ऋण / इक्विटी (MRQ) | 0.45Y औसत ≈0.5 | ≈0.5 | 0.2 | उच्च ऋण | |
| वर्तमान अनुपात (MRQ) | 1.85Y औसत ≈2.3 | ≈2.3 | 1.8 | अनुरूप | |
| Quick Ratio (त्वरित अनुपात) | 1.35Y औसत ≈1.5 | ≈1.5 | 1.0 | मजबूत तरलता | |
| दीर्घकालिक ऋण / इक्विटी (MRQ) | 0.45Y औसत ≈0.5 | ≈0.5 | 0.4 | अनुरूप |
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
| मेट्रिक | 5Y रुझान | RVTY | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Revenue YoY (राजस्व YoY) | 3.7%5Y औसत ≈-5.1% | ≈-5.1% | · | · | |
| Revenue CAGR 3Y (राजस्व CAGR 3Y) | -4.8%5Y औसत ≈-8.4% | ≈-8.4% | · | · | |
| Revenue CAGR 5Y (राजस्व CAGR 5Y) | -5.5% | · | · | · | |
| EPS YoY | -5.9%5Y औसत ≈-12.6% | ≈-12.6% | · | · | |
| Net Income YoY (शुद्ध आय YoY) | -10.8%5Y औसत ≈-12.0% | ≈-12.0% | · | · | |
| EPS CAGR 3Y | -22.8%5Y औसत ≈-21.0% | ≈-21.0% | · | · | |
| EPS CAGR 5Y | -20.4% | · | · | · | |
| Net Income CAGR 3Y (शुद्ध आय CAGR 3Y) | -24.9%5Y औसत ≈-20.2% | ≈-20.2% | · | · | |
| Net Income CAGR 5Y (शुद्ध आय CAGR 5Y) | -19.8% | · | · | · |
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
| मेट्रिक | 5Y रुझान | RVTY | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Asset Turnover (परिसंपत्ति टर्नओवर) | 0.25Y औसत ≈0.3 | ≈0.3 | 0.6 | कमजोर | |
| Receivables Turnover (प्राप्य टर्नओवर) | 4.15Y औसत ≈4.5 | ≈4.5 | 5.5 | कमजोर | |
| Revenue / Employee (राजस्व / कर्मचारी (रिपोर्ट की गई हेडकाउंट, यफाइनांस)। व्युत्पन्न — संग्रहीत SEC-XBRL अवधारणा नहीं है।) | ≈$259.6K | · | · | · |
मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय
लाभांश यील्ड, भुगतान अनुपात, लाभांश इतिहास, 5Y CAGR
| एक्स-डेट | राशि | मुद्रा | यील्ड |
|---|---|---|---|
| जुल 17, 2026 | $0.07 | USD | ≈0.25% |
| अप्र 17, 2026 | $0.07 | USD | ≈0.30% |
| जन 16, 2026 | $0.07 | USD | ≈0.25% |
| अक्ट 17, 2025 | $0.07 | USD | ≈0.30% |
| जुल 18, 2025 | $0.07 | USD | ≈0.30% |
| अप्र 17, 2025 | $0.07 | USD | ≈0.30% |
| जन 17, 2025 | $0.07 | USD | ≈0.24% |
| अक्ट 18, 2024 | $0.07 | USD | ≈0.23% |
| जुल 19, 2024 | $0.07 | USD | ≈0.26% |
| अप्र 18, 2024 | $0.07 | USD | ≈0.28% |
| जन 18, 2024 | $0.07 | USD | ≈0.26% |
| अक्ट 19, 2023 | $0.07 | USD | ≈0.28% |
| जुल 20, 2023 | $0.07 | USD | ≈0.22% |
| अप्र 20, 2023 | $0.07 | USD | ≈0.21% |
| जन 19, 2023 | $0.07 | USD | ≈0.21% |
| अक्ट 20, 2022 | $0.07 | USD | ≈0.22% |
| जुल 21, 2022 | $0.07 | USD | ≈0.19% |
| अप्र 21, 2022 | $0.07 | USD | ≈0.18% |
| जन 20, 2022 | $0.07 | USD | ≈0.16% |
| अक्ट 21, 2021 | $0.07 | USD | ≈0.16% |
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
| Period | रिपोर्ट | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|---|
| 30 जून 2026 | जुल 27, 2026 | $1.41 | $1.25 | 13.1% |
| 31 मार्च 2026 | $1.06 | $1.04 | 2.3% | |
| 31 दिसमबर 2025 | $1.70 | $1.58 | 7.4% | |
| 30 सितमबर 2025 | $1.18 | $1.16 | 1.7% | |
| 30 जून 2025 | $1.18 | $1.16 | 1.5% | |
| 31 मार्च 2025 | $1.01 | $0.97 | 4.3% |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.86B | $2.76B | $2.75B | $3.31B | $3.83B | $3.78B | $2.88B | $2.78B | $2.26B | $2.12B | $2.10B | $2.24B | |
| Cost of Revenue | · | · | · | · | · | · | · | $1.44B | $709M | $665M | $696M | $708M | |
| Gross Profit | · | · | · | $1.99B | $2.43B | $2.11B | $1.40B | $1.34B | $1.07B | $1.01B | $964M | $1.00B | |
| R&D Expense | $216M | $197M | $217M | $222M | $200M | $146M | $189M | $194M | $139M | $124M | $113M | $108M | |
| SG&A Expense | $992M | $994M | $1.02B | $1.03B | $975M | $716M | $815M | $812M | $626M | $590M | $587M | $648M | |
| Operating Income | $357M | $347M | $301M | $743M | $1.26B | $867M | $362M | $324M | $296M | $295M | $251M | $165M | |
| Interest Expense | · | · | · | · | · | $50M | $64M | $67M | $44M | $42M | $38M | $36M | |
| Interest Income | $31M | $73M | $72M | $4M | $2M | $1M | $1M | $1M | $3M | $702.0K | $673.0K | $667.0K | |
| Other Non-op | $-88M | $-31M | $-118M | $-91M | $-3M | $-5M | $-6M | $-13M | $43M | $-15M | $-5M | $-6M | |
| Pretax Income | $268M | $316M | $183M | $652M | $1.20B | $800M | $237M | $258M | $297M | $244M | $209M | $124M | |
| Income Tax | $28M | $33M | $3M | $139M | $314M | $170M | $9M | $20M | $140M | $28M | $20M | $-6M | |
| Net Income | $241M | $270M | $693M | $569M | $943M | $728M | $228M | $238M | $293M | $234M | $212M | $158M | |
| EPS (Basic) | $2.07 | $2.21 | $5.56 | $4.51 | $8.12 | $6.52 | $2.06 | $2.15 | $2.67 | $2.14 | $1.89 | $1.40 | |
| EPS (Diluted) | $2.07 | $2.20 | $5.55 | $4.50 | $8.08 | $6.49 | $2.04 | $2.13 | $2.64 | $2.12 | $1.87 | $1.39 | |
| Shares (Basic) | 116,542,000 | 122,756,000 | 124,704,000 | 126,155,000 | 116,165,000 | 111,514,000 | 110,827,000 | 110,561,000 | 109,857,000 | 109,478,000 | 112,507,000 | 112,593,000 | |
| Shares (Diluted) | 116,595,000 | 122,822,000 | 124,812,000 | 126,426,000 | 116,674,000 | 112,085,000 | 111,501,000 | 111,534,000 | 110,859,000 | 110,313,000 | 113,315,000 | 113,739,000 | |
| EBITDA | $762M | $775M | $732M | $1.17B | $1.69B | $1.23B | $576M | $504M | $410M | $383M | $398M | $327M |
बैलेंस शीट
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $920M | $1.16B | $913M | $454M | $603M | $387M | $192M | $163M | $202M | $359M | $238M | $175M | |
| Short-term Investments | · | $0 | $690M | $0 | · | · | · | · | · | · | · | · | |
| Receivables | $745M | $632M | $633M | $613M | $708M | $1.16B | $725M | $633M | $552M | $426M | $415M | $471M | |
| Inventory | $379M | $368M | $428M | $405M | $426M | $515M | $357M | $338M | $352M | $247M | $259M | $285M | |
| Other Current Assets | $196M | $186M | $337M | $122M | $148M | $167M | $100M | $101M | $94M | $99M | $64M | $138M | |
| Current Assets | $2.24B | $2.35B | $3.00B | $3.29B | $2.44B | $2.24B | $1.37B | $1.23B | $1.20B | $1.19B | $1.03B | $1.07B | |
| PP&E (Net) | $479M | $482M | $510M | $483M | $486M | $368M | $318M | $319M | $298M | $145M | $138M | $176M | |
| PP&E (Gross) | $1.09B | $982M | $983M | $857M | $844M | $818M | $702M | $680M | $631M | $428M | $402M | $493M | |
| Accum. Depreciation | $614M | $500M | $473M | $374M | $359M | $450M | $383M | $362M | $333M | $282M | $264M | $317M | |
| Goodwill | $6.61B | $6.46B | $6.53B | $6.48B | $6.63B | $2.64B | $3.11B | $2.95B | $3.00B | $2.25B | $2.24B | $2.24B | |
| Intangibles | $2.35B | $2.64B | $3.02B | $3.38B | $3.82B | $1.37B | $1.28B | $1.20B | $1.35B | $420M | $486M | $490M | |
| Other Non-current Assets | $323M | $288M | $343M | $311M | $317M | $333M | $284M | $270M | $244M | $205M | $198M | $107M | |
| Total Assets | $12.17B | $12.39B | $13.56B | $14.13B | $15.00B | $7.96B | $6.54B | $5.98B | $6.09B | $4.28B | $4.17B | $4.13B | |
| Accounts Payable | $185M | $167M | $204M | $273M | $325M | $327M | $236M | $221M | $222M | $168M | $141M | $174M | |
| Accrued Liabilities | $557M | $485M | $524M | $528M | $679M | $944M | $503M | $529M | $501M | $400M | $382M | $403M | |
| Current Liabilities | $1.33B | $653M | $1.45B | $1.54B | $1.21B | $1.65B | $763M | $772M | $951M | $603M | $561M | $597M | |
| Capital Leases | $148M | $152M | $133M | $170M | $147M | $188M | $146M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $30M | |
| Other Non-current Liabilities | $807M | $771M | $931M | $1.11B | $1.43B | $775M | $751M | $742M | $849M | $460M | $465M | $443M | |
| Total Liabilities | $4.92B | $4.73B | $5.69B | $6.75B | $7.86B | $4.22B | $3.72B | $3.39B | $3.59B | $2.12B | $2.06B | $2.09B | |
| Long-term Debt | $3.22B | $3.15B | $3.90B | $4.39B | $4.98B | $1.99B | $2.07B | $1.89B | $2.01B | $1.05B | $480M | $1.05B | |
| Total Debt | $3.22B | $3.15B | $3.90B | $4.39B | $4.98B | $1.61B | $2.06B | $1.88B | $1.79B | $1.05B | $1.01B | $1.05B | |
| Common Stock | $112M | $121M | $123M | $126M | $126M | $112M | $111M | $111M | $110M | $110M | $112M | $112M | |
| Retained Earnings | $6.05B | $5.85B | $5.61B | $4.95B | $4.42B | $3.51B | $2.81B | $2.60B | $2.38B | $2.12B | $1.99B | $1.81B | |
| AOCI | $-222M | $-396M | $-277M | $-447M | $-163M | $-32M | $-200M | $-176M | $-47M | $-101M | $-46M | $25M | |
| Stockholders' Equity | $7.25B | $7.67B | $7.87B | $7.38B | $7.14B | $3.74B | $2.81B | $2.58B | $2.50B | $2.15B | $2.11B | $2.04B | |
| Liabilities + Equity | $12.17B | $12.39B | $13.56B | $14.13B | $15.00B | $7.96B | $6.54B | $5.98B | $6.09B | $4.28B | $4.17B | $4.13B | |
| Shares Outstanding | 112,281,000 | 120,646,000 | 0 | 126,300,000 | 126,241,000 | 112,090,000 | 111,140,000 | 110,361,000 | 110,361,000 | 109,617,000 | 112,481,000 | 112,481,000 |
नकदी प्रवाह
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $405M | $428M | $432M | $427M | $311M | $202M | $214M | $181M | $105M | $100M | $105M | $110M | |
| Stock-based Comp | $23M | $38M | $41M | $52M | $30M | $27M | $32M | $29M | $25M | $17M | $17M | $14M | |
| Deferred Tax | $-61M | $-102M | $-124M | $-106M | $-55M | $-35M | $-61M | $-51M | $29M | $-5M | $-10M | $-34M | |
| Amort. of Intangibles | $336M | $359M | $365M | $371M | $257M | $161M | $164M | $136M | $74M | $72M | $77M | $81M | |
| Restructuring | · | $18M | $27M | $14M | $-14M | $8M | $29M | $11M | $13M | $5M | $14M | $13M | |
| Other Non-cash | $-25M | $-6M | $-951M | $-262M | $126M | $-82M | $-48M | $-85M | $-163M | $4M | $-48M | $26M | |
| Operating Cash Flow | $583M | $628M | $91M | $680M | $1.41B | $892M | $363M | $311M | $288M | $351M | $287M | $282M | |
| CapEx | $74M | $87M | $81M | $86M | $86M | $64M | $76M | $93M | $39M | $32M | $28M | $27M | |
| Investing Cash Flow | $-17M | $776M | $1.31B | $-133M | $-4.11B | $-504M | $-488M | $-160M | $-1.27B | $-84M | $-101M | $-296M | |
| Stock Repurchased | $821M | $370M | $389M | $81M | $73M | $7M | $6M | $57M | $4M | $152M | $76M | $66M | |
| Net Stock Activity | $-821M | $-370M | $-389M | $-81M | $-73M | $-7M | $-6M | $-57M | $-4M | $-152M | $-76M | $-66M | |
| Dividends Paid | $33M | $34M | $35M | $35M | $32M | $31M | $31M | $31M | $31M | $31M | $32M | $32M | |
| Financing Cash Flow | $-858M | $-1.13B | $-947M | $-662M | $2.94B | $-203M | $-150M | $-179M | $782M | $-115M | $-107M | $31M | |
| Net Change in Cash | $-243M | $250M | $444M | $-149M | $217M | $211M | $26M | $-36M | $-174M | $138M | $63M | $2M | |
| Taxes Paid | $131M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $509M | $542M | $10M | $594M | $1.31B | $815M | $287M | $218M | $249M | $319M | $257M | $253M | |
| Levered FCF | · | · | · | · | · | $775M | $226M | $156M | $226M | $282M | $224M | $218M |
लाभप्रदता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 60.1% | · | 55.8% | 48.4% | 48.3% | 47.5% | 47.9% | 45.3% | 44.9% | |
| Operating Margin | 12.5% | 12.6% | 10.9% | 22.4% | 26.3% | 25.9% | 12.6% | 11.7% | 13.5% | 13.4% | 12.7% | 9.4% | |
| Net Margin | 8.5% | 9.8% | 25.2% | 17.2% | 18.6% | 19.2% | 7.9% | 8.6% | 13.0% | 11.1% | 9.4% | 7.0% | |
| Pretax Margin | 9.4% | 11.5% | 6.7% | 19.7% | 25.3% | 24.0% | 8.2% | 9.3% | 13.2% | 11.5% | 10.8% | 7.6% | |
| EBITDA Margin | 26.7% | 28.1% | 26.6% | 35.3% | 33.4% | 32.4% | 20.0% | 18.2% | 18.2% | 18.1% | 17.6% | 14.6% | |
| ROA | 2.0% | 2.1% | 5.0% | 3.9% | 8.2% | 10.0% | 3.6% | 3.9% | 5.6% | 5.5% | 5.1% | 3.9% | |
| ROE | 3.3% | 3.5% | 8.9% | 7.9% | 13.4% | 20.9% | 8.2% | 9.2% | 12.6% | 11.0% | 10.2% | 7.8% | |
| ROIC | 3.0% | 2.9% | 2.5% | 5.0% | 8.1% | 14.7% | 7.1% | 6.7% | 3.8% | 7.8% | 8.0% | 6.5% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 3.6 | 2.1 | 2.1 | 2.0 | 1.4 | 1.8 | 1.6 | 1.3 | 2.0 | 1.8 | 1.8 | |
| Quick Ratio | 1.3 | 2.7 | 1.5 | 0.7 | 1.4 | 0.9 | 1.2 | 1.0 | 0.8 | 1.3 | 1.2 | 1.1 | |
| Debt / Equity | 0.4 | 0.4 | 0.5 | 0.6 | 0.7 | 0.4 | 0.7 | 0.7 | 0.7 | 0.5 | 0.5 | 0.5 | |
| LT Debt / Equity | 0.4 | 0.4 | 0.4 | 0.5 | 0.7 | 0.4 | 0.7 | 0.7 | 0.7 | 0.5 | 0.5 | 0.5 | |
| Interest Coverage | · | · | · | · | · | 19.7 | 5.7 | 4.8 | 6.9 | 6.8 | 7.5 | 5.8 |
दक्षता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | 0.2 | 0.2 | 0.4 | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | |
| Inventory Turnover | · | · | · | · | · | · | · | 4.2 | 2.4 | 2.6 | 2.8 | 2.9 | |
| Receivables Turnover | 4.1 | 4.4 | 4.4 | 5.0 | 4.7 | 4.0 | 4.2 | 4.7 | 4.6 | 5.0 | 5.0 | 4.8 |
प्रति शेयर
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $64.57 | $63.55 | $63.79 | $58.46 | $56.57 | $33.33 | $25.44 | $23.37 | $22.68 | $19.22 | $18.84 | $18.16 | |
| Revenue / Share | $24.50 | $22.43 | $22.04 | $26.20 | $43.43 | $33.75 | $25.86 | $24.91 | $20.36 | $19.18 | $19.97 | $19.67 | |
| Cash Flow / Share | $5.00 | $5.12 | $0.73 | $5.38 | $12.09 | $7.96 | $3.26 | $2.79 | $2.60 | $3.18 | $2.53 | $2.48 | |
| Cash / Share | $8.19 | $9.64 | $7.40 | $3.60 | $4.90 | $3.59 | $1.73 | $1.47 | $1.83 | $3.21 | $2.12 | $1.55 | |
| Dividend / Share | $0.28 | $0.28 | $0.28 | $0.28 | · | $0.28 | $0.28 | $0.28 | $0.28 | $0.28 | $0.28 | $0.28 | |
| EPS (TTM) | $2.07 | $2.20 | $5.55 | $4.50 | $8.08 | $6.49 | $2.04 | $2.13 | $2.64 | $2.12 | $1.87 | $1.39 |
विकास दरें
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 3.7% | 0.16% | -17.0% | -13.5% | 1.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -4.8% | -10.4% | -10.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -5.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -5.9% | -60.4% | 23.3% | -44.3% | 24.5% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -22.8% | -35.2% | -5.1% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -20.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -10.8% | -61.0% | 21.8% | -39.6% | 29.6% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -24.9% | -34.1% | -1.6% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -19.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 1.0% | · | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.86B | $2.76B | $2.75B | $3.31B | $3.83B | $3.78B | $2.88B | $2.78B | $2.26B | $2.12B | $2.10B | $2.24B | |
| Net Income TTM | $241M | $270M | $693M | $569M | $943M | $728M | $228M | $238M | $293M | $234M | $212M | $158M | |
| Market Cap | $10.86B | $13.51B | $13.49B | $17.71B | $25.38B | $16.08B | $10.73B | $8.55B | $8.07B | $5.84B | $6.00B | $4.96B | |
| Enterprise Value | $13.16B | $15.50B | $15.79B | $21.65B | $29.74B | $17.29B | $12.61B | $10.26B | $9.66B | $6.53B | $6.78B | $5.83B | |
| P/E | 46.7 | 50.9 | 19.7 | 31.2 | 24.9 | 22.1 | 47.6 | 36.3 | 27.7 | 24.6 | 28.6 | 31.7 | |
| P/S | 3.8 | 4.9 | 4.9 | 5.3 | 6.6 | 4.3 | 3.7 | 3.1 | 3.6 | 2.8 | 2.9 | 2.2 | |
| P/B | 1.5 | 1.8 | 1.7 | 2.4 | 3.6 | 4.3 | 3.8 | 3.3 | 3.2 | 2.7 | 2.8 | 2.4 | |
| P / Cash Flow | 18.6 | 21.5 | 147.8 | 26.1 | 18.0 | 18.0 | 29.5 | 27.5 | 28.0 | 16.7 | 20.9 | 17.6 | |
| P / FCF | 21.3 | 24.9 | 1362.2 | 29.8 | 19.4 | 19.7 | 37.4 | 39.2 | 32.4 | 18.3 | 23.3 | 19.6 | |
| EV / EBITDA | 17.3 | 20.0 | 21.6 | 18.5 | 17.6 | 14.1 | 21.9 | 20.3 | 23.6 | 17.0 | 17.0 | 17.8 | |
| EV / FCF | 25.8 | 28.6 | 1594.1 | 36.4 | 22.7 | 21.2 | 43.9 | 47.1 | 38.7 | 20.5 | 26.3 | 23.1 | |
| EV / Revenue | 4.6 | 5.6 | 5.7 | 6.5 | 7.8 | 4.6 | 4.4 | 3.7 | 4.3 | 3.1 | 3.2 | 2.6 | |
| Dividend Yield | 0.30% | 0.26% | 0.26% | 0.20% | 0.13% | 0.19% | 0.29% | 0.36% | 0.38% | 0.53% | 0.53% | 0.64% | |
| Earnings Yield | 2.1% | 2.0% | 5.1% | 3.2% | 4.0% | 4.5% | 2.1% | 2.8% | 3.6% | 4.1% | 3.5% | 3.1% | |
| Payout Ratio | 13.6% | 12.7% | 5.0% | 6.2% | 3.4% | 4.3% | 13.7% | 13.0% | 10.5% | 13.2% | 14.9% | 20.0% | |
| Annual Payout | $33M | $34M | $35M | $35M | $32M | $31M | $31M | $31M | $31M | $31M | $32M | $32M |
आय विवरण
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $730M | $711M | $772M | $699M | $720M | $665M | $729M | $684M | $692M | $650M | $403M | $709M | $-120M | |
| Cost of Revenue | $313M | $323M | · | $324M | $328M | $289M | · | $299M | $306M | $295M | · | $307M | · | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | · | $436M | |
| R&D Expense | $49M | $58M | $58M | $51M | $53M | $54M | $49M | $49M | $48M | $50M | $45M | $57M | $40M | |
| SG&A Expense | $279M | $254M | $252M | $242M | $249M | $250M | $244M | $238M | $252M | $261M | $232M | $267M | $229M | |
| Operating Income | $89M | $76M | $112M | $82M | $91M | $72M | $119M | $98M | $86M | $44M | $-116M | $78M | $-290M | |
| Interest Expense | · | · | · | · | · | · | · | · | $25M | $24M | · | $26M | · | |
| Interest Income | $5M | $6M | $6M | $7M | $8M | $10M | $10M | $23M | $21M | $20M | $41M | $25M | $2M | |
| Other Non-op | $21M | $-26M | $-77M | $-4M | $13M | $-20M | $-26M | $-1M | $43M | $-10M | $-27M | $-7M | $-66M | |
| Pretax Income | $64M | $50M | $92M | $56M | $69M | $52M | $95M | $100M | $87M | $35M | $-143M | $72M | $-361M | |
| Income Tax | $10M | $9M | $-4M | $8M | $13M | $11M | $6M | $7M | $14M | $6M | $-55M | $13M | $-87M | |
| Net Income | $52M | $41M | $98M | $47M | $54M | $42M | $95M | $94M | $55M | $26M | $-89M | $36M | $-166M | |
| EPS (Basic) | $0.47 | $0.36 | $0.86 | $0.40 | $0.46 | $0.35 | $0.78 | $0.77 | $0.45 | $0.21 | $-0.63 | $0.28 | $-2.50 | |
| EPS (Diluted) | $0.47 | $0.36 | $0.86 | $0.40 | $0.46 | $0.35 | $0.77 | $0.77 | $0.45 | $0.21 | $-0.63 | $0.28 | $-2.48 | |
| Shares (Basic) | 111,584,000 | 111,852,000 | · | 115,411,000 | 117,512,000 | 120,137,000 | · | 122,810,000 | 123,354,000 | 123,428,000 | · | 125,215,000 | · | |
| Shares (Diluted) | 111,629,000 | 111,876,000 | · | 115,463,000 | 117,538,000 | 120,233,000 | · | 123,026,000 | 123,477,000 | 123,538,000 | · | 125,398,000 | · | |
| EBITDA | $89M | $181M | · | $82M | $91M | $170M | · | $98M | $86M | $152M | · | $78M | · |
बैलेंस शीट
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.02B | $860M | $920M | $931M | $992M | $1.14B | $1.16B | $1.23B | $1.25B | $998M | $913M | $1.33B | $454M | |
| Short-term Investments | · | · | · | · | · | · | · | $0 | $706M | $697M | · | $739M | · | |
| Receivables | $709M | $691M | $745M | $680M | $661M | $617M | $632M | $602M | $597M | $589M | · | $627M | · | |
| Inventory | $379M | $388M | $379M | $380M | $388M | $381M | $368M | $405M | $401M | $414M | · | $437M | · | |
| Other Current Assets | $187M | $189M | $196M | $152M | $195M | $182M | $186M | $212M | $206M | $361M | · | $389M | · | |
| Current Assets | $2.30B | $2.13B | $2.24B | $2.14B | $2.24B | $2.32B | $2.35B | $2.45B | $3.16B | $3.06B | · | $3.52B | · | |
| PP&E (Net) | $456M | $466M | $479M | $497M | $499M | $487M | $482M | $518M | $503M | $504M | · | $491M | · | |
| PP&E (Gross) | · | · | $1.09B | · | · | · | $982M | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $614M | · | · | · | $500M | · | · | · | · | · | · | |
| Goodwill | $6.61B | $6.61B | $6.61B | $6.60B | $6.61B | $6.51B | $6.46B | $6.56B | $6.50B | $6.50B | $6.53B | $6.52B | $6.48B | |
| Intangibles | $2.22B | $2.31B | $2.35B | $2.43B | $2.51B | $2.57B | $2.64B | $2.76B | $2.83B | $2.92B | · | $3.20B | · | |
| Other Non-current Assets | $309M | $322M | $323M | $300M | $321M | $300M | $288M | $332M | $297M | $298M | · | $322M | · | |
| Total Assets | $12.05B | $12.00B | $12.17B | $12.14B | $12.36B | $12.36B | $12.39B | $12.77B | $13.42B | $13.43B | · | $14.22B | · | |
| Accounts Payable | $166M | $170M | $185M | $176M | $178M | $178M | $167M | $176M | $175M | $184M | · | $236M | · | |
| Accrued Liabilities | $538M | $493M | $557M | $463M | $493M | $470M | $485M | $510M | $504M | $479M | · | $652M | · | |
| Current Liabilities | $1.28B | $1.24B | $1.33B | $1.22B | $672M | $648M | $653M | $688M | $1.39B | $1.37B | · | $1.37B | · | |
| Capital Leases | $136M | $142M | $148M | $154M | $160M | $157M | $152M | $128M | $123M | $127M | · | $144M | · | |
| Other Non-current Liabilities | $771M | $801M | $807M | $755M | $760M | $750M | $771M | $846M | $879M | $920M | · | $954M | · | |
| Total Liabilities | $4.82B | $4.81B | $4.92B | $4.76B | $4.81B | $4.72B | $4.73B | $4.85B | $5.55B | $5.59B | · | $6.35B | · | |
| Long-term Debt | $3.21B | $3.21B | $3.22B | $3.21B | $3.21B | $3.17B | $3.15B | $3.19B | $3.87B | $3.88B | · | $4.36B | · | |
| Total Debt | $3.21B | $3.21B | · | $3.21B | $3.21B | $3.17B | · | $3.19B | $3.87B | $3.88B | · | · | · | |
| Common Stock | $112M | $112M | $112M | $114M | $116M | $119M | $121M | $122M | $123M | $123M | · | $124M | · | |
| Retained Earnings | $6.13B | $6.09B | $6.05B | $5.96B | $5.93B | $5.88B | $5.85B | $5.76B | $5.67B | $5.63B | · | $5.54B | · | |
| AOCI | $-257M | $-254M | $-222M | $-180M | $-157M | $-316M | $-396M | $-232M | $-342M | $-325M | $-277M | $-305M | $-447M | |
| Stockholders' Equity | $7.23B | $7.18B | $7.25B | $7.38B | $7.56B | $7.64B | $7.67B | $7.92B | $7.87B | $7.85B | $7.87B | $7.87B | $7.38B | |
| Liabilities + Equity | $12.05B | $12.00B | $12.17B | $12.14B | $12.36B | $12.36B | $12.39B | $12.77B | $13.42B | $13.43B | · | $14.22B | · | |
| Shares Outstanding | 111,584,000 | 111,629,000 | 112,281,000 | 114,030,000 | 116,331,000 | 119,409,000 | 120,646,000 | 122,091,000 | 123,368,000 | 123,492,000 | 0 | 124,347,000 | 0 |
नकदी प्रवाह
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $102M | $105M | $103M | $102M | $103M | $97M | $105M | $108M | $106M | $108M | $106M | · | $104M | |
| Stock-based Comp | $11M | $9M | $-4M | $9M | $10M | $8M | $5M | $11M | $12M | $12M | $7M | · | $12M | |
| Amort. of Intangibles | $85M | $85M | $84M | $84M | $85M | $83M | $88M | $90M | $91M | $91M | $85M | $93M | $163M | |
| Other Non-cash | · | $-39M | · | · | · | $-19M | · | · | · | $2M | · | · | · | |
| Operating Cash Flow | $192M | $115M | $182M | $138M | $134M | $128M | $174M | $148M | $243M | $148M | $197M | · | $139M | |
| CapEx | $11M | $20M | $20M | $19M | $19M | $16M | $24M | $22M | $19M | $18M | $24M | · | $26M | |
| Investing Cash Flow | $-4M | $-78M | $-20M | $19M | $-9M | $-6M | $-17M | $690M | $-1.76B | $-18M | $-415M | · | $-26M | |
| Stock Repurchased | $16M | $86M | $168M | $205M | $294M | $154M | $185M | $154M | $-31M | $11M | $5M | · | $25M | |
| Net Stock Activity | · | $-86M | · | · | · | $-154M | · | · | · | $-11M | · | · | · | |
| Dividends Paid | $8M | $8M | $8M | $8M | $8M | $8M | $9M | $9M | $8M | $9M | $9M | · | $9M | |
| Financing Cash Flow | $-23M | $-89M | $-176M | $-215M | $-302M | $-164M | $-193M | $-874M | $52M | $-35M | $-20M | · | $-77M | |
| Net Change in Cash | $163M | $-60M | $-12M | $-60M | $-146M | $-26M | $-66M | $-19M | $-1.46B | $85M | $-224M | · | $54M | |
| Free Cash Flow | · | $95M | · | · | · | $112M | · | · | · | $130M | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $109M | · | · | · |
लाभप्रदता
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.2% | 10.7% | · | 11.7% | 12.6% | 10.9% | · | 14.3% | 12.4% | 6.8% | · | 11.0% | · | |
| Net Margin | 7.1% | 5.7% | · | 6.7% | 7.5% | 6.3% | · | 13.8% | 8.0% | 4.0% | · | 5.0% | · | |
| Pretax Margin | 8.7% | 7.0% | · | 8.0% | 9.5% | 7.9% | · | 14.7% | 12.5% | 5.3% | · | 10.1% | · | |
| EBITDA Margin | 12.2% | 25.4% | · | 11.7% | 12.6% | 25.5% | · | 14.3% | 12.4% | 23.4% | · | 11.0% | · | |
| ROA | 0.42% | 0.33% | · | 0.37% | 0.42% | 0.33% | · | 0.72% | 0.40% | 0.19% | · | · | · | |
| ROE | 0.70% | 0.55% | · | 0.61% | 0.70% | 0.55% | · | 1.2% | 0.70% | 0.33% | · | · | · | |
| ROIC | 0.72% | 0.60% | · | 0.66% | 0.68% | 0.53% | · | 0.82% | 0.61% | 0.31% | · | · | · |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.7 | · | 1.8 | 3.3 | 3.6 | · | 3.6 | 2.3 | 2.2 | · | · | · | |
| Quick Ratio | 1.4 | 1.3 | · | 1.3 | 2.5 | 2.7 | · | 2.7 | 1.8 | 1.7 | · | · | · | |
| Debt / Equity | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | · | · | |
| LT Debt / Equity | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | 3.5 | 1.8 | · | 3.0 | · |
दक्षता
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | · | · | |
| Inventory Turnover | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | · | · | |
| Receivables Turnover | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | · | · |
प्रति शेयर
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $64.78 | $64.34 | · | $64.68 | $64.95 | $63.96 | · | $64.88 | $63.80 | $63.54 | · | · | · | |
| Revenue / Share | $6.54 | $6.36 | · | $6.05 | $6.13 | $5.53 | · | $5.56 | $5.60 | $5.26 | · | $5.65 | · | |
| Cash Flow / Share | · | $1.03 | · | · | · | $1.07 | · | · | · | $1.19 | · | · | · | |
| Cash / Share | $9.17 | $7.71 | · | $8.17 | $8.53 | $9.53 | · | $10.07 | $10.12 | $8.08 | · | · | · | |
| Dividend / Share | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | |
| Dividend Paid / Share | · | · | · | · | · | · | · | $0.07 | $0.07 | $0.07 | · | $0.07 | · | |
| EPS (TTM) | $2.09 | $2.08 | · | $1.98 | $2.35 | $2.34 | · | $0.80 | $0.11 | $-0.06 | · | · | $4.50 |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.91B | $2.90B | · | $2.81B | $2.80B | $2.77B | · | $2.43B | $2.42B | $2.43B | · | · | $3.31B | |
| Net Income TTM | · | · | · | $237M | $285M | $287M | · | $87M | $2M | $-18M | · | · | $569M | |
| Market Cap | $12.69B | $9.93B | · | $9.59B | $11.38B | $12.61B | · | $15.39B | $12.94B | $12.97B | · | · | · | |
| Enterprise Value | $14.88B | $12.28B | · | $11.87B | $13.60B | $14.64B | · | $17.35B | $14.86B | $15.15B | · | · | · | |
| P/E | 54.4 | 42.8 | · | 42.5 | 41.6 | 45.1 | · | 157.6 | 953.3 | -1750.0 | · | · | 31.2 | |
| P/S | 4.4 | · | · | 3.4 | 4.1 | 4.6 | · | 6.3 | 5.4 | 5.3 | · | · | · | |
| P/B | 1.8 | 1.4 | · | 1.3 | 1.5 | 1.7 | · | 1.9 | 1.6 | 1.7 | · | · | · | |
| P / Cash Flow | · | 86.2 | · | · | · | 98.4 | · | · | · | 87.9 | · | · | · | |
| EV / Revenue | 5.1 | · | · | 4.2 | 4.9 | 5.3 | · | 7.1 | 6.1 | 6.2 | · | · | · | |
| Dividend Yield | 0.25% | · | · | 0.35% | 0.30% | 0.27% | · | 0.22% | 0.27% | · | · | · | · | |
| Earnings Yield | 1.8% | 2.3% | · | 2.4% | 2.4% | 2.2% | · | 0.63% | 0.10% | -0.06% | · | · | 3.2% | |
| Payout Ratio | · | 19.2% | · | · | · | 20.0% | · | · | · | 33.2% | · | · | · | |
| Annual Payout | $32M | $32M | · | $33M | $34M | $34M | · | $34M | $34M | · | · | · | $35M |
सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
| मेट्रिक | 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 | 2022-01-02 |
|---|---|---|---|---|---|
| राजस्व | $2.86B | $2.76B | $2.75B | $3.31B | $3.83B |
| सकल मार्जिन % | · | · | · | 60.1% | · |
| परिचालन मार्जिन % | 12.5% | 12.6% | 10.9% | 22.4% | 26.3% |
| शुद्ध आय | $241M | $270M | $693M | $569M | $943M |
| तनुकरणित EPS | $2.07 | $2.20 | $5.55 | $4.50 | $8.08 |
| मेट्रिक | 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 | 2022-01-02 |
|---|---|---|---|---|---|
| ऋण / इक्विटी | 0.4 | 0.4 | 0.5 | 0.6 | 0.7 |
| वर्तमान अनुपात | 1.7 | 3.6 | 2.1 | 2.1 | 2.0 |
| त्वरित अनुपात | 1.3 | 2.7 | 1.5 | 0.7 | 1.4 |
| मेट्रिक | 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 | 2022-01-02 |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $509M | $542M | $10M | $594M | $1.31B |
संस्थागत मालिक (13F) 576 फाइलर्स · $11.1B कुल · तिथि अनुसार 30 सितमबर 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 101 (+19 पिछली तिमाही की तुलना में) | 53 (-14 पिछली तिमाही की तुलना में) | 195 (+16 पिछली तिमाही की तुलना में) | 163 (+4 पिछली तिमाही की तुलना में) | -8.8M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1273316785 | 13160897 | 11.42% | शेयर |
| EdgePoint Investment Group Inc. | $950658734 | 8544479 | 8.53% | शेयर |
| BlackRock, Inc. | $852070090 | 7658369 | 7.64% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $812306256 | 7300973 | 7.29% | शेयर |
| JANUS HENDERSON GROUP PLC | $731386229 | 8348127 | 6.56% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $530760044 | 4770448 | 4.76% | शेयर |
| STATE STREET CORP | $483173141 | 4342739 | 4.33% | शेयर |
| VICTORY CAPITAL MANAGEMENT INC | $384362134 | 3454630 | 3.45% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $381477581 | 3428692 | 3.42% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $328197297 | 2955227 | 2.94% | शेयर |
| MORGAN STANLEY | $286475399 | 2574826 | 2.57% | शेयर |
| Invesco Ltd. | $269802164 | 2424970 | 2.42% | शेयर |
| Allspring Global Investments Holdings, LLC | $251393303 | 2227874 | 2.25% | शेयर |
| NEUBERGER BERMAN GROUP LLC | $208728363 | 1876041 | 1.87% | शेयर |
| UBS Group AG | $207440264 | 1864464 | 1.86% | शेयर |
| Pictet Asset Management Holding SA | $181501112 | 1631343 | 1.63% | शेयर |
| CITADEL ADVISORS LLC | $162143092 | 1457335 | 1.45% | शेयर |
| RGM Capital, LLC | $147000789 | 1519388 | 1.32% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $120784746 | 1085608 | 1.08% | शेयर |
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. | $120187725 | 1080242 | 1.08% | शेयर |
| NORTHERN TRUST CORP | $105092080 | 944563 | 0.94% | शेयर |
| GOLDMAN SACHS GROUP INC | $100173074 | 900351 | 0.90% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $96303874 | 865575 | 0.86% | शेयर |
| NORGES BANK | $96183046 | 864489 | 0.86% | शेयर |
| PRIMECAP MANAGEMENT CO/CA/ | $94921470 | 853150 | 0.85% | शेयर |
| BANK OF AMERICA CORP /DE/ | $87116298 | 782997 | 0.78% | शेयर |
| Bank of New York Mellon Corp | $78765533 | 707941 | 0.71% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $69620945 | 625750 | 0.62% | शेयर |
| JANE STREET GROUP, LLC | $64087317 | 576014 | 0.57% | शेयर |
| JPMORGAN CHASE & CO | $54177057 | 481955 | 0.49% | शेयर |
| FMR LLC | $51807384 | 465642 | 0.46% | शेयर |
| SEI INVESTMENTS CO | $48628856 | 437074 | 0.44% | शेयर |
| Quantinno Capital Management LP | $47076898 | 423125 | 0.42% | शेयर |
| DEUTSCHE BANK AG\ | $45437583 | 408391 | 0.41% | शेयर |
| FEDERATED HERMES, INC. | $43043267 | 386871 | 0.39% | शेयर |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $42868033 | 385296 | 0.38% | शेयर |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $41752209 | 476569 | 0.37% | शेयर |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $41048042 | 368938 | 0.37% | शेयर |
| Freestone Grove Partners LP | $36716134 | 330003 | 0.33% | शेयर |
| Legal & General Group Plc | $31388230 | 282116 | 0.28% | शेयर |
| CIBC Bancorp USA Inc. | $29112955 | 261625 | 0.26% | शेयर |
| Nuveen, LLC | $27202014 | 244491 | 0.24% | शेयर |
| California Public Employees Retirement System | $27021271 | 242866 | 0.24% | शेयर |
| BNP PARIBAS FINANCIAL MARKETS | $25920242 | 232970 | 0.23% | शेयर |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $25784587 | 294311 | 0.23% | शेयर |
| Vanguard Global Advisers, LLC | $25557201 | 229707 | 0.23% | शेयर |
| Swiss National Bank | $24955618 | 224300 | 0.22% | शेयर |
| CIBC Private Wealth Group LLC | $23946556 | 273207 | 0.21% | शेयर |
| Artisan Partners Limited Partnership | $22320536 | 200616 | 0.20% | शेयर |
| Meridiem Capital Partners LP | $21483638 | 193094 | 0.19% | शेयर |
कार्यकर्ता और 5%+ मालिक 2 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| PERKINELMER, INC. | 16 सितमबर 2011 | · | प्रारंभिक फाइलिंग | M&A / बिक्री | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 23 जुलाई 2001 | · | प्रारंभिक फाइलिंग | M&A / बिक्री | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
कंपनी के अंदरूनी सूत्र 46 इनसाइडर्स · 27 अधिकारी · 20 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Robert F Friel | Chairman and CEO | 13 फ़रवरी 2019 F | 570662 | 0 | 0 | $0 |
| Maxwell Krakowiak | Senior Vice President and Chief Financial Officer | 21 सितमबर 2026 S | 14781 | 0 | 1 | $-235728 |
| James M Mock | Senior Vice President and Chief Financial Officer | 24 जून 2022 S | 27577 | 0 | 0 | $0 |
| Frank Anders Wilson | Senior Vice President and Chief Financial Officer | 5 मार्च 2018 M | 61925 | 0 | 0 | $0 |
| Jeffrey D Capello | SVP & CFO | 29 जनवरी 2008 A | 91428 | 0 | 0 | $0 |
| John Patrick Murphy | Chief Operating Officer | 1 अगस्त 2005 M | 68589 | 0 | 0 | $0 |
| Anita Gonzales | VP and CAO | 1 अक्टूबर 2026 S | 7117 | 0 | 3 | $-29790 |
| Tajinder Vohra | Senior Vice President, Global Operations | 16 सितमबर 2026 S | 6635 | 0 | 2 | $-1634152 |
| Joel S Goldberg | Senior Vice President, Administration, General Counsel and Secretary | 14 अगस्त 2026 G | 91494 | 0 | 4 | $-1274357 |
| Miriame Victor | Senior Vice President, Chief Commercial Officer | 24 फ़रवरी 2026 M | 18122 | 0 | 1 | $-180856 |
| Daniel R Tereau | Senior Vice President, Strategy and Business Development | 5 फ़रवरी 2024 A | 13246 | 0 | 0 | $0 |
| Andrew Okun | Vice President, Chief Accounting Officer and Treasurer | 13 अप्रैल 2023 M | 4356 | 0 | 0 | $0 |
| Deborah A. Butters | Senior Vice President, Chief Human Resources Officer | 7 फ़रवरी 2020 F | 12383 | 0 | 0 | $0 |
| James Corbett | Executive Vice President and President, Discovery & Analytical Solutions | 30 अप्रैल 2019 F | 40531 | 0 | 0 | $0 |
| Jonathan P. Divincenzo | Senior Vice President and President, Environmental Health | 9 फ़रवरी 2016 A | 23158 | 0 | 0 | $0 |
| John R Letcher | Senior Vice President, Human Resources | 5 जून 2015 D | 26894 | 0 | 0 | $0 |
| Maurice H. Tenney | Senior Vice President, Global Operations and Customer Logistics | 7 नवमबर 2014 D | 12241 | 0 | 0 | $0 |
| Daniel R Marshak | SVP & CSO | 26 सितमबर 2014 D | 67743 | 0 | 0 | $0 |
| Kevin E Hrusovsky | Senior Vice President, President Life Sciences and Technology | 31 मई 2013 D | 0 | 0 | 0 | $0 |
| John A Roush | Senior Vice President | 9 फ़रवरी 2010 A | 120407 | 0 | 0 | $0 |
| Richard F Walsh | SVP & CAO | 26 जनवरी 2010 D | 183491 | 0 | 0 | $0 |
| Gregory L Summe | Exe. Chairman of the Board | 27 फ़रवरी 2009 S | 231724 | 0 | 0 | $0 |
| Michael Louis Battles | VP & Chief Accounting Officer | 3 फ़रवरी 2009 A | 33750 | 0 | 0 | $0 |
| Katherine A Ohara | SVP, Gen. Counsel, & Secretary | 29 जनवरी 2008 A | 65886 | 0 | 0 | $0 |
| Peter B Coggins | Sr. Vice President | 28 अक्टूबर 2005 M | 87070 | 0 | 0 | $0 |
| Robert A Barrett | Sr. Vice President | 3 मार्च 2004 M | 2333 | 0 | 0 | $0 |
| Terrance L Carlson | Sr. VP & General Counsel | 27 जनवरी 2004 J | 2759 | 0 | 0 | $0 |
| Alexis P. Michas | निदेशक | 25 अगस्त 2026 G | 6985 | 0 | 0 | $0 |
| Michelle Mcmurry-Heath | निदेशक | 7 मई 2026 A | 6513 | 0 | 1 | $-58356 |
| Michael A Klobuchar | निदेशक | 7 मई 2026 A | 7368 | 0 | 0 | $0 |
| Pascale Witz | निदेशक | 7 मई 2026 A | 15985 | 0 | 0 | $0 |
| Samuel R. Chapin | निदेशक | 7 मई 2026 A | 22676 | 0 | 0 | $0 |
| Michel Vounatsos | निदेशक | 7 मई 2026 A | 13977 | 0 | 0 | $0 |
| Frank Witney | निदेशक | 7 मई 2026 A | 23354 | 0 | 0 | $0 |
| Sophie V. Vandebroek | निदेशक | 7 मई 2026 A | 7368 | 0 | 0 | $0 |
| Peter Barrett | निदेशक | 7 मई 2026 A | 28293 | 0 | 0 | $0 |
| Sylvie Gregoire | निदेशक | 15 मई 2023 A | 20482 | 0 | 0 | $0 |
| SULLIVAN PATRICK J | निदेशक | 30 अप्रैल 2019 A | 30580 | 0 | 0 | $0 |
| Nicholas A Lopardo | निदेशक | 5 फ़रवरी 2019 S | 39635 | 0 | 0 | $0 |
| Vicki L Sato | निदेशक | 9 फ़रवरी 2017 M | 29970 | 0 | 0 | $0 |
| Kenton J Sicchitano | निदेशक | 24 अगस्त 2016 M | 27971 | 0 | 0 | $0 |
| MULLEN JAMES C | निदेशक | 14 नवमबर 2014 M | 45551 | 0 | 0 | $0 |
| Gabriel Schmergel | निदेशक | 16 फ़रवरी 2012 M | 48012 | 0 | 0 | $0 |
| Robert G Tod | निदेशक | 14 फ़रवरी 2012 M | 42824 | 0 | 0 | $0 |
| Tamara J Erickson | निदेशक | 14 फ़रवरी 2007 S | 15352 | 0 | 0 | $0 |
| Prahlad R. Singh | · | 13 अगस्त 2026 G | 59650 | 0 | 5 | $-2557859 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
ईटीएफ स्वामित्व 96 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| RSPH · Invesco Exchange-Traded Fund Trust | 2.02% | 115244 SH | 1 अक्टूबर 2026 | दैनिक |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.13% | 6936 NS | 31 जुलाई 2026 | N-PORT |
| ALTL · Pacer Funds Trust | 0.98% | 8002 NS | 31 जुलाई 2026 | N-PORT |
| SPHB · Invesco Exchange-Traded Fund Trust … | 0.87% | 53854 SH | 1 अक्टूबर 2026 | दैनिक |
| HIBL · Direxion Shares ETF Trust | 0.66% | 4421 NS | 31 जुलाई 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0.50% | 14749 NS | 31 जुलाई 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.43% | 313113 NS | 31 जुलाई 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0.43% | 39813 NS | 31 जुलाई 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.36% | 14789 NS | 31 जुलाई 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.35% | 444437 NS | 31 जुलाई 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0.34% | 37032 SH | 1 अक्टूबर 2026 | दैनिक |
| BKMC · BNY Mellon ETF Trust | 0.32% | 18499 NS | 31 जुलाई 2026 | N-PORT |
| ESML · iShares Trust | 0.29% | 66388 SH | 11 सितमबर 2026 | दैनिक |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.27% | 49018 NS | 31 जुलाई 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.26% | 1624934 SH | 19 अगस्त 2026 | दैनिक |
| RSP · Invesco Exchange-Traded Fund Trust | 0.25% | 1580743 SH | 1 अक्टूबर 2026 | दैनिक |
| IYH · iShares Trust | 0.22% | 65502 SH | 11 सितमबर 2026 | दैनिक |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.21% | 8343 NS | 31 जुलाई 2026 | N-PORT |
| SMMD · iShares Trust | 0.19% | 59552 SH | 11 सितमबर 2026 | दैनिक |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0.18% | 5732000 | 1 अक्टूबर 2026 | दैनिक |
| FHLC · FIDELITY COVINGTON TRUST | 0.18% | 53129 NS | 31 जुलाई 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.18% | 335880 SH | 19 अगस्त 2026 | दैनिक |
| DFAS · Dimensional ETF Trust | 0.18% | 241849 NS | 31 जुलाई 2026 | N-PORT |
| ISCG · iShares Trust | 0.18% | 13989 SH | 11 सितमबर 2026 | दैनिक |
| IXJ · iShares Trust | 0.17% | 58518 SH | 11 सितमबर 2026 | दैनिक |
| REVS · Columbia ETF Trust I | 0.17% | 4910 NS | 31 जुलाई 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0.15% | 2559509 SH | 19 अगस्त 2026 | दैनिक |
| CURE · Direxion Shares ETF Trust | 0.14% | 2195 NS | 31 जुलाई 2026 | N-PORT |
| IWS · iShares Trust | 0.13% | 167213 SH | 11 सितमबर 2026 | दैनिक |
| WSML · iShares Trust | 0.13% | 7071 SH | 11 सितमबर 2026 | दैनिक |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.12% | 6239 SH | 1 अक्टूबर 2026 | दैनिक |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0.12% | 8519 NS | 31 जुलाई 2026 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0.11% | 4047000 | 1 अक्टूबर 2026 | दैनिक |
| RECS · Columbia ETF Trust I | 0.11% | 55761 NS | 31 जुलाई 2026 | N-PORT |
| PEXL · Pacer Funds Trust | 0.10% | 460 NS | 31 जुलाई 2026 | N-PORT |
| IWR · iShares Trust | 0.10% | 456822 SH | 11 सितमबर 2026 | दैनिक |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0.08% | 113000 | 1 अक्टूबर 2026 | दैनिक |
| XT · iShares Trust | 0.08% | 25072 SH | 11 सितमबर 2026 | दैनिक |
| XOEF · iShares Trust | 0.08% | 142 SH | 11 सितमबर 2026 | दैनिक |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.08% | 9258 NS | 31 जुलाई 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.07% | 4175 SH | 1 अक्टूबर 2026 | दैनिक |
| DFAC · Dimensional ETF Trust | 0.06% | 238422 NS | 31 जुलाई 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.05% | 2685 NS | 31 जुलाई 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0.05% | 33073 SH | 1 अक्टूबर 2026 | दैनिक |
| DFSU · Dimensional ETF Trust | 0.05% | 10422 NS | 31 जुलाई 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.05% | 65386 NS | 31 जुलाई 2026 | N-PORT |
| IVE · iShares Trust | 0.05% | 185121 SH | 11 सितमबर 2026 | दैनिक |
| IUSV · iShares Trust | 0.04% | 98188 SH | 11 सितमबर 2026 | दैनिक |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.04% | 25806 SH | 19 अगस्त 2026 | दैनिक |
| DSI · iShares Trust | 0.04% | 17178 SH | 11 सितमबर 2026 | दैनिक |
| DCOR · Dimensional ETF Trust | 0.04% | 11339 NS | 31 जुलाई 2026 | N-PORT |
| CHRI · Global X Funds | 0.04% | 27 NS | 31 जुलाई 2026 | N-PORT |
| IWD · iShares Trust | 0.04% | 247738 SH | 11 सितमबर 2026 | दैनिक |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.03% | 3353 SH | 1 अक्टूबर 2026 | दैनिक |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.03% | 67429 SH | 19 अगस्त 2026 | दैनिक |
| TOPC · iShares Trust | 0.03% | 72 SH | 11 सितमबर 2026 | दैनिक |
| PBP · Invesco Exchange-Traded Fund Trust | 0.03% | 660 SH | 1 अक्टूबर 2026 | दैनिक |
| TILT · FlexShares Trust | 0.02% | 4536 NS | 31 जुलाई 2026 | N-PORT |
| XVV · iShares Trust | 0.02% | 1280 SH | 11 सितमबर 2026 | दैनिक |
| DFAU · Dimensional ETF Trust | 0.02% | 24920 NS | 31 जुलाई 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0.02% | 89 SH | 30 सितमबर 2026 | दैनिक |
| XYLG · Global X Funds | 0.02% | 120 NS | 31 जुलाई 2026 | N-PORT |
| IVV · iShares Trust | 0.02% | 1406050 SH | 11 सितमबर 2026 | दैनिक |
| XYLD · Global X Funds | 0.02% | 5804 NS | 31 जुलाई 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0.02% | 2897314 SH | 19 अगस्त 2026 | दैनिक |
| VTI · VANGUARD INDEX FUNDS | 0.02% | 3545801 SH | 19 अगस्त 2026 | दैनिक |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.02% | 18403 SH | 19 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.02% | 9418 SH | 19 अगस्त 2026 | दैनिक |
| ESGV · VANGUARD WORLD FUND | 0.02% | 25220 SH | 19 अगस्त 2026 | दैनिक |
| IYY · iShares Trust | 0.02% | 4913 SH | 11 सितमबर 2026 | दैनिक |
| PTLC · Pacer Funds Trust | 0.02% | 5733 NS | 31 जुलाई 2026 | N-PORT |
| IWB · iShares Trust | 0.02% | 77050 SH | 11 सितमबर 2026 | दैनिक |
| XCLR · Global X Funds | 0.02% | 6 NS | 31 जुलाई 2026 | N-PORT |
| ITOT · iShares Trust | 0.02% | 147486 SH | 11 सितमबर 2026 | दैनिक |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.02% | 11723 SH | 1 अक्टूबर 2026 | दैनिक |
| IWV · iShares Trust | 0.02% | 30674 SH | 11 सितमबर 2026 | दैनिक |
| DFUS · Dimensional ETF Trust | 0.02% | 33978 NS | 31 जुलाई 2026 | N-PORT |
| XRMI · Global X Funds | 0.02% | 81 NS | 31 जुलाई 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0.02% | 421 NS | 31 जुलाई 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0.02% | 2684 NS | 31 जुलाई 2026 | N-PORT |
| XTR · Global X Funds | 0.02% | 7 NS | 31 जुलाई 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0.02% | 779 NS | 31 जुलाई 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0.01% | 8723 NS | 31 जुलाई 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.01% | 3445 SH | 1 अक्टूबर 2026 | दैनिक |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 98929 SH | 19 अगस्त 2026 | दैनिक |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 जुलाई 2026 | दैनिक |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 14 जुलाई 2026 | दैनिक |
| ISCB · iShares Trust | · | 5032 SH | 11 सितमबर 2026 | दैनिक |
| ISCV · iShares Trust | · | 15028 SH | 11 सितमबर 2026 | दैनिक |
RVTY विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
12-महीने का मूल्य लक्ष्य
16 विश्लेषक · 2026-09-28माध्य लक्ष्य $129.00 -14.9%
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| RVTY | $10.86B | 46.7 | 3.7% | 8.5% | 3.3% | · |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | · |
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | · |
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | · |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | · |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
| TXG | $2.08B | -46.6 | 5.2% | -6.8% | -5.5% | 69.0% |
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।